PPP1R11 is a specific inhibitor of Protein Phosphatase 1 (PP1), a major serine/threonine phosphatase that regulates a variety of cellular functions. PP1 is involved in numerous cellular processes, including cell division, protein synthesis, and muscle contraction. The regulatory subunits of PP1, such as PPP1R11, play a crucial role in targeting PP1 to specific subcellular locations and modulating its activity .
PPP1R11 exhibits differential sensitivity towards the metal-independent and metal-dependent forms of PP1. It acts as an atypical E3 ubiquitin-protein ligase, which ubiquitinates Toll-like receptor 2 (TLR2) at lysine 754, leading to its degradation by the proteasome. This process is essential for regulating inflammatory cytokine release and gram-positive bacterial clearance .
The regulation of PP1 by PPP1R11 is critical for maintaining cellular homeostasis. Dysregulation of PP1 activity can lead to various diseases, including cancer, diabetes, and neurodegenerative disorders. Understanding the role of PPP1R11 in these pathways can provide insights into potential therapeutic targets for these conditions .
Recombinant human PPP1R11 is used in research to study its inhibitory effects on PP1 and its role in various cellular processes. The recombinant protein is produced using recombinant DNA technology, which involves inserting the PPP1R11 gene into an expression vector, transforming it into a host cell, and purifying the expressed protein.